Objective: Cytokine-induced killer (CIK) cells represent a realistic approach in cancer immunotherapy with confirmed survival benefits in the context of met
Objective: To evaluate radiochemotherapeutic sequence for pathological stage N2 rectal cancer in the era of oxaliplatin-based adjuvant therapy.Method: Treat